GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#5)

Company

Addex Therapeutics Ltd.

Filed

December 8, 2023

Accession Number

0001072613-23-000611